Mark A. Gohr
Directeur Financier/CFO chez ANTH1, Inc.
Profil
Mark A.
Gohr is currently the Chief Financial & Accounting Officer at ANTH1, Inc. He completed his undergraduate degree at Hastings College and his graduate degree at The University of Colorado.
Postes actifs de Mark A. Gohr
| Sociétés | Poste | Début |
|---|---|---|
ANTH1, Inc.
 ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Directeur Financier/CFO | 17/06/2010 |
Formation de Mark A. Gohr
| The University of Colorado | Graduate Degree |
| Hastings College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
ANTH1, Inc.
ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Health Technology |
